Products

INIFY Prostate
ContextVision
Clinical Decision Support & Reference
INIFY Prostate is an AI-based decision support tool that accurately outlines suspicious prostate cancer areas in digitalized prostate biopsy samples.

See all 1 product →

About ContextVision

ContextVision is a medical technology software company specializing in image analysis and artificial intelligence, established in 1983 in Sweden. The company is a global market leader in image enhancement and a trusted partner to leading original equipment manufacturers (OEMs) of ultrasound, X-ray, and Magnetic Resonance Imaging (MRI) equipment. Their proprietary software solutions are designed to improve the quality of medical images, leading to faster and more reliable diagnostics and interventions for patients worldwide.

For physicians, ContextVision’s cutting-edge technology helps in accurately interpreting medical images, which is a crucial foundation for better diagnosis and treatment. Their products, such as the Rivent platform for ultrasound and Altumira for digital radiography, offer enhanced image clarity, diagnostic confidence, and workflow efficiency. The company is also expanding into data quality and AI-enabled quantitative imaging, with a focus on developing digital biomarkers for early detection and monitoring of liver diseases, including Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). This involves strategic partnerships with institutions like the University of Washington and AMRA Medical to advance multimodal imaging and create non-invasive diagnostic tools.

Focus Areas

medical image analysis artificial intelligence image enhancement digital pathology ultrasound X-ray MRI data quality physiological quantification biomarkers liver disease diagnostics breast cancer thyroid nodule screening

Business Intelligence

Key Investorsunknown
PartnershipsBeamWorks Inc., AMRA Medical, University of Washington, University of Waterloo's LITMUS Lab, InPhase Solutions AS
AcquisitionsVistinct (exclusive rights to 3D-rendering technology for ultrasound imaging)
TechnologyProprietary software solutions, image processing software platform, deep learning algorithms, AI-based decision support tools
FDA Clearancesunknown cleared products (estimated)

What Physicians Need to Know

Medical Image Analysis & AI
ContextVision specializes in image analysis and artificial intelligence, developing powerful software products based on proprietary technology and AI for image-based applications. They are a global market leader in image enhancement, partnering with manufacturers of ultrasound, X-ray, and MRI equipment.
Image Enhancement (Ultrasound, X-ray, MRI)
ContextVision offers cutting-edge image enhancement software for various modalities, including 2D/3D/4D ultrasound, X-ray (static and dynamic digital X-ray), and MRI. Their solutions aim to deliver unparalleled image clarity, improve contrast, reduce noise, sharpen edges, and enhance visualization of details.
Digital Pathology
ContextVision has been developing innovative products within digital pathology, including their INIFY Prostateu2122 product. They are strategically shifting their pathology business to focus on establishing an AI-based pathology lab service.
Data Quality & Physiological Quantification Biomarkers
ContextVision is pioneering a new 'Data Quality' business aimed at machine-aided interpretation, extending beyond their traditional 'Image Quality' focus. This initiative focuses on building AI-powered, organ-specific quantitative imaging solutions to improve physiological quantification from imaging modalities and enable the implementation of digital biomarkers.
Liver Disease Diagnostics (MASLD)
A significant focus is on advancing liver disease diagnostics, particularly for Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD). They are developing AI-powered, organ-specific imaging solutions and multimodal biomarkers by integrating MRI and ultrasound technologies for earlier detection and treatment planning.
Breast Cancer & Thyroid Nodule Screening
ContextVision is involved in AI-driven biomarker development for real-time ultrasound focused on breast cancer and thyroid nodule screening. Their ultrasound image enhancement packages also aid in detecting soft-tissue lesions during breast exams and improving visualization for thyroid nodule evaluation.
Physician Tip

ContextVision's solutions are designed to provide faster and more reliable diagnostics and interventions. Physicians can expect enhanced image clarity across ultrasound, X-ray, and MRI, leading to increased diagnostic confidence and improved workflow efficiency. The company's focus on AI-powered organ-specific solutions and digital biomarkers, particularly in liver disease, breast cancer, and thyroid nodule screening, aims to offer more accurate, scalable, and non-invasive diagnostic tools, potentially transforming patient outcomes through earlier and smarter detection.

ContextVision's image enhancement solutions are designed for seamless integration with OEM (Original Equipment Manufacturers) medical imaging systems. They offer versatile and scalable post-processing software solutions that can be implemented in all types of systems and optimized for specific needs. Their products are delivered with an SDK, and the image processing library is a .dll file, allowing for highly configurable designs customized for each system.

Products by ContextVision

1 product in the directory

INIFY Prostate
ContextVision
Clinical Decision Support & Reference
INIFY Prostate is an AI-based decision support tool that accurately outlines suspicious prostate cancer areas in digitalized prostate biopsy samples.

What the Web Says

ContextVision is a company specializing in medical image enhancement software, particularly for ultrasound and X-ray applications. They develop real-time volumetric filtering software to improve image quality by reducing artifacts and enhancing contrast. The company emphasizes a positive working environment and strong company culture, with a focus on employee well-being.

Overall: Positive

Strengths

  • Innovative software solutions for medical image enhancement (ultrasound, X-ray).
  • Products like GOPiCE US and US PlusView improve image quality, reduce speckle, and enhance contrast for better diagnostic confidence.
  • Adaptable to various ultrasound hardware platforms.
  • Positive working environment and strong company culture.
  • Focus on employee well-being and health.
  • High employee Net Promoter Score (eNPS) in 2023.

Limitations

  • Limited recent public reviews on major platforms like G2, Glassdoor, Capterra, and Reddit specifically for ContextVision, making it difficult to gauge widespread current sentiment.
  • Some search results for 'Vision' or 'Context' related companies on review sites show mixed or negative feedback, but these are not directly attributable to ContextVision.
  • Older product information (2009, 2013) found, suggesting a need for more current product reviews.

Based on reviews from: ContextVision (Career page), AuntMinnie.com, openPR.com

Last updated: 2026-08-05

Videos

News, demos, and interviews about ContextVision.

Loading videos...

Videos load interactively. If none appear, search YouTube for ContextVision →

View all on YouTube

Press & Coverage

ContextVision
BULLETIN FROM THE ANNUAL GENERAL MEETING OF CONTEXTVISION AB (PUBL)
ContextVision held its Annual General Meeting on May 12, 2026, where decisions were made regarding the adoption of the income statement and balance sheet.
2026-05
ContextVision
ContextVision AB: Q1 interim report 2026 - Solid progress and disciplined execution in a stabilising market
ContextVision released its Q1 2026 interim report, highlighting continued execution in a stabilizing market with approximately 7.4% underlying revenue growth and a strategic R&D collaboration with BeamWorks.
2026-05
ContextVision
ContextVision partners with BeamWorks to advance AI-powered quantitative ultrasound imaging solutions
ContextVision announced a strategic research and development collaboration with BeamWorks Inc. to advance AI-powered quantitative ultrasound imaging solutions, focusing on real-time point-of-care diagnostics.
2026-03
TradingView / Euronext Markets
ContextVision announces changes to its management team and strengthens its technology leadership with appointment of new CTO
ContextVision appointed Marco Marien Voormolen as Chief Technology Officer, strengthening its technology leadership and management team as the company transitions towards quantitative imaging solutions.
2026-03
Inderes.dk
ContextVision initiates the clinical phase of its point-of-care ultrasound innovation venture to advance liver disease diagnostics
ContextVision announced the first patient visit in its clinical development program for liver disease diagnostics at the University of Washington, marking a major milestone in its AI-based liver imaging program.
2025-10
Cision News
ContextVision and AMRA Medical join forces to advance multimodal imaging in liver disease diagnostics
ContextVision and AMRA Medical partnered to advance multimodal imaging in liver disease diagnostics, combining MRI and ultrasound to develop accurate, scalable, and non-invasive diagnostic tools for MASLD.
2025-05
ContextVision
ContextVision and the University of Washington sign a partnership agreement to advance liver disease diagnosis
ContextVision partnered with the University of Washington to advance liver disease diagnosis, focusing on developing AI-based solutions for organ-specific imaging data and physiological quantification biomarkers.
2025-02
Inderes.dk
ContextVision AB: Result of the offer to buy back own shares
ContextVision announced the result of its offer to buy back up to 3,000,000 shares, with the company resolving to buy back 1,205,735 shares at NOK 6.50 per share.
2024-12

Frequently Asked Questions

ContextVision specializes in enhancing medical images from ultrasound, X-ray, and MRI equipment. Their technology, which incorporates artificial intelligence and deep learning, aims to improve image quality, leading to more accurate and reliable diagnoses for patients. For example, their Altumirau2122 platform uses AI for advanced image enhancement in digital X-ray, including scatter correction and improved noise suppression.
ContextVision is expanding into a 'Data Quality' business, which focuses on machine-aided interpretation and developing organ-specific applications to improve physiological quantification from imaging modalities. They are actively developing digital biomarkers for early detection and monitoring of liver diseases like MASLD (Metabolic dysfunction-associated steatotic liver disease) through partnerships with institutions like the University of Washington and AMRA Medical. Additionally, they are involved in AI-powered ultrasound solutions for breast cancer and thyroid nodule screening.
ContextVision has made significant investments in AI technology for digital pathology. While they previously developed decision support tools, they have strategically shifted to focus on establishing an AI-based pathology lab service. This new strategy leverages their machine learning technology for their own laboratory services, aiming to improve cancer diagnosis.
ContextVision prioritizes product safety and effectiveness, aiming to comply with applicable laws, regulations, and standards. The company is certified according to EN ISO 13485:2016, which specifies requirements for a quality management system for medical devices. They also have a policy in place to ensure compliance with General Data Protection Regulations (GDPR).
ContextVision partners with leading manufacturers of medical imaging equipment (OEMs) globally, customizing solutions to enhance image quality. They engage in strategic collaborations to anticipate and adapt to future industry trends, offering support and assistance based on their experience in various clinical environments. Their Data Quality initiative also involves partnerships with academic centers and other medical technology companies to advance research and development in areas like liver disease diagnostics.
ContextVision has a strong financial position with no external debt and a solid net cash position, which supports ongoing investments in innovation and market expansion. They have consistently shown profitability and are committed to long-term growth. The company is strategically investing in AI-enabled quantitative imaging and expanding into the data quality market, which they anticipate will be a significant growth area.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

Tempus AI is a leading health technology company that leverages artificial intelligence (AI) and machine learning to advance precision medicine. Founded in 2015 by Eric Lefkofsky, the company was inspired by the need for more data-driven approaches in oncology care. Tempus has since built one of the world’s largest libraries of multimodal clinical and molecular […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]

SureMediks, a product of Rasimo Systems, LLC, is an AI-powered Clinical Operating System designed for longitudinal care, aiming to transform episodic healthcare into continuous, intelligent, and personalized patient management. The platform integrates patients, healthcare providers, clinical protocols, AI, connected medical devices, and electronic medical records into a unified ecosystem. SureMediks processes continuous real-world patient data […]

SOAP Health is a healthcare AI company focused on improving early disease detection and diagnosis at the point of care. The company’s mission is to save lives by augmenting physicians’ capabilities to perform in-depth risk and symptom assessments. They aim to achieve this by leveraging conversational and generative AI to enhance patient intake, streamline risk […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.